Skip to main content

This site is currently implementing core features and is not ready for patient use yet.

Yellow Fever

Febris flava

Vaccine-preventable4tropicalmosquito-bornevaccine availablehigh mortality

Overview

Yellow fever is a viral disease transmitted by mosquitoes of the Aedes and Haemagogus genera. It occurs endemically in tropical regions of Africa and South America. The disease can progress mildly or severely, with symptoms of fever, jaundice, and hemorrhages.

Epidemiological Data

Reproduction Rate (R₀)

4.81

Mortality Rate

39%

Infectious Period

3-5 dni

Detailed Symptoms

Fever, headache, muscle pain, nausea, vomiting, jaundice, hemorrhages, kidney failure.

Symptoms

biegunka
Atypical5
nudności
Atypical2
ból głowy
Atypical4
dreszcze
Atypical3
zołte gałki oczne
Atypical5

Treatment

Treatment is symptomatic - rest, hydration, antipyretics. In severe cases, hospitalization is necessary.

Course of Disease

The disease can progress mildly (viremic phase) or severely (toxic phase) with jaundice and hemorrhages.

Complications

No complication data available.

Prevention Details

The most effective prevention method is yellow fever vaccination, which provides protection for 10 years.

Prevention

No prevention data available.

Epidemiology

The disease occurs endemically in tropical regions of Africa and South America. It is estimated that 200,000 cases occur annually.

Risk Factors

Traveling to endemic areas without vaccination, being outdoors during mosquito activity hours.

Indications

Vaccination is recommended for all travelers to yellow fever endemic areas, especially in Africa and South America.

Diagnosis

Diagnosis is based on clinical symptoms, laboratory tests, and serological tests.

Prognosis

Prognosis depends on disease severity. In mild cases, prognosis is good; in severe cases, mortality can be 20-50%.

Names & Synonyms

Common Names

Yellow Fever

Alternative Names

Febris flavaYellow Jack

Vaccines

Yellow feverWHO Code: J07BL01
Learn more

Manufacturer: Sanofi Pasteur, Sanofi Pasteur, Bio-Manguinhos / Fiocruz, Chumakov Institute, Wuhan Institute of Biological Products

Content Warnings

This information is for educational purposes only and does not replace professional medical advice.

Review Information

Last reviewed by

Medical Team

Review notes

Content reviewed and updated regularly

Medical Information

Transmission
wektorowa, kropelkowa, powietrzna, pokarmowa
Incubation Period
3 - 6 days
Infectious Period
3-5 dni
Mortality Rate
39%
Reproduction Rate (R₀)
4.81
Causative Agent
Wirus żółtej gorączki
ICD Codes
ICD-10: A95 | ICD-11: 1D47
Vaccine-preventable
Yes

Critical Information

Reporting Required

Reporting Procedure

  1. Identify and confirm the case
  2. Notify the local health authority within 24 hours
  3. Complete the official notification form
  4. Submit laboratory confirmation if available
  5. Follow up with the health authority as required
Important: Failure to report can result in legal consequences and hinders outbreak control.

Emergency Signs

High fever
jaundice
hemorrhages
consciousness disorders
breathing difficulties.

When to Seek Help

Immediate medical help is necessary in case of jaundice
hemorrhages
or consciousness disorders.

Prevention Measures

Yellow fever vaccination
use of repellents
wearing long clothing
avoiding outdoor activities during mosquito activity hours.

Contraindications

Yellow fever vaccine is contraindicated in people with severe allergy to vaccine components
immunocompromised individuals
pregnant women
and children under 9 months of age.

Complications Details

Severe complications include liver
kidney
and heart failure
hemorrhages
shock
and death.

Travel Advice

Before traveling to endemic areas
you should get vaccinated against yellow fever. Vaccination is required in some countries.

Also known as

Yellow FeverUrban Yellow FeverJungle Yellow FeverYellow JackFebris flava